You are using an older browser version. Please use a supported version for the best MSN experience.

Genova Biopharma Gets EUA For GEMCOVAC-19 Vax: Health Experts Discuss| News Centre | CNBC-TV18

Genova Biopharmaceuticals has become the first indigenously developed mRNA Covid-19 vaccine to be approved for restricted emergency use in adults. To talk more about its efficacy, we are joined in by Dr. Sanjay Singh, the CEO of Genova Biopharmaceuticals and Samit Mehta, President- Operations of Emcure Pharmaceutical and COO of Genova Biopharmaceuticals.#drsanjaysingh #samitmehta #genovabiopharmaceuticals #mrnacovidvaccine #businessnews #businessnewstoday #businessnewsinenglish #sharemarkettoday #n18oc_business #cnbctv18 About CNBC-TV18:

UP NEXT

UP NEXT

More From CNBCTV18

More From CNBCTV18

image beaconimage beaconimage beacon